MS

Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confirmed that Ireland’s Primary Care Reimbursement Service (‘PCRS’) has approved Althea THC20:CBD1 cannabis oil for...

Biogen, Inc. (NASDAQ: BIIB) disclosed in its second-quarter earnings report that it recorded $900 million related to a settlement agreement to resolve previously disclosed "qui tam" litigation related to its conduct before 2015. Qui tam is a type of whistleblower...

It was the year 2000. "The Montel Williams Show," one of the longest running talk shows in television history, was at its prime, making millions for CBS Corporation (NYSE: CBS). Montel was on a plane flying to Utah to record a guest part for "Touched by an Angel," when he felt...

TV personality Montel Williams was one of the keynote speakers at the Viridian Cannabis Investment Series, hosted by Viridian Capital Advisors at the John Jay School of Criminal Justice in New York City. Before his moving, personal speech on medical marijuana and the importance of patient care,...

Biogen Inc (NASDAQ: BIIB) announced that anti-Lingo failed both the primary and the secondary endpoints in its Phase 2 RRMS trial. Citi’s Robyn Karnauskas downgraded the rating on the company from Buy to Neutral, while lowering the price target from $345 to $295. Lingo Failure “While...

After the release of positive data for Roche Holding Ltd. (ADR) (OTC: RHHBY)’s Ocrelizumab this weekend, Credit Suisse updated its model for the drug. The firm maintains an Outperform rating and $320.00 price target on the stock. Shares of Roche are up 1 percent on Tuesday trading. In a...